Ortho Clinical Diagnostics - a Johnson & Johnson Company.

Global Sites:  United Kingdom (English)
Skip navigation links
    
The art of communicating.

The art of communicating.

 

Media | Press Releases



OCD LAUNCHES NEW VIRTUAL ENGAGEMENT PLATFORM FOR THE BLOOD BANKING COMMUNITY

Ortho Clinical Diagnostics Improves Oncology Testing Portfolio with Expanded PSA Offerings

ORTHO CLINICAL DIAGNOSTICS RECEIVES CE MARKING ON VITAMIN D TOTAL ASSAY

Introducing the new VITROS® Immunodiagnostic Products Syphilis TPA Assay

ORTHO CLINICAL DIAGNOSTICS LAUNCHES “BLOODLINES” BRAND CAMPAIGN INSPIRED BY BLOOD BANKERS

Ortho Clinical Diagnostics Announces Availability of Seven Manufacturer-Validated Applications for Thermo Fisher Scientific Immunoassays (July 26, 2011)

Ortho Clinical Diagnostics Launches VITROS® 4600 Chemistry System for Mid- to High-Volume Laboratories (July 22, 2011)

Ortho Clinical Diagnostics Receives FDA Clearance for Intact Parathyroid Hormone Assay (Nov. 1, 2010)

FDA Approves VITROS® Hepatitis B Surface Antigen Assay for Use on VITROS® 5600 Integrated and VITROS® 3600 Immunodiagnotic Systems (Oct. 26, 2009)

Ortho Clinical Diagnostics Launches 24-Hour Remote Monitoring Center (July 21, 2009)

VITROS® 5600 Integrated System Wins International Product Design Awards

Two Next Generation Clinical Diagnostics Platforms Now Available in Europe (Jan. 15, 2009)

VITROS® 3600 IMMUNODIAGNOSTIC SYSTEM RECEIVES 510(K) CLEARANCE FROM THE FDA (Dec. 23, 2008)

FDA CLEARS VITROS® 5600 INTEGRATED SYSTEM FOR LABORATORY DIAGNOSTICS (Oct. 24, 2008)

Johnson & Johnson Nordic AB Acquires AMIC (June 18, 2008)

Veridex Announces Agreement To Acquire The Assets of Immunicon Corporation (June 11, 2008)

Blood Donations in U.S. Testing Positive for Chagas’ Disease (Oct. 20, 2007)


This site is published by Ortho-Clinical Diagnostics, which is solely responsible for the content. Registered in England No: 2549777. © All contents copyright Ortho-Clinical Diagnostics, 2003-2013 unless otherwise noted. Product availability is subject to fulfillment of regulatory requirements in each market. This site was written for and is intended for Healthcare Professionals in the United Kingdom only. Last Modified Date:19/11/2008 18:14